WELCOME TO The HEALTHCARE REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Health Technology, Medical Devices
Signify Health | January 12, 2023
Signify Health, a top healthcare platform that uses advanced analytics, technology, and nationwide healthcare networks, announced a new partnership with Prospect Medical Holdings, Inc., a growing healthcare services company on January 11, 2023. The collaboration will help create and run value-based payment programs for superior care.
To improve care transformation, manage risk, and provide high-quality, coordinated patient care for its traditional Medicare fee-for-service patien...
HITInfrastructure | January 16, 2020
Arizona-based Banner Health recently implemented a digital triage platform that aims to help consumers and patients navigate the 28-hospital health system using artificial intelligence, according to a recent announcement. The platform, Buoy Assistant from Buoy Health, aims to empower healthcare consumers by helping them navigate their healthcare journey through clinician-curated content. For example, the artificial intelligence-power assistant can guide users to an appropriate benefit and preven...
MedCity News | January 30, 2020
Microsoft unveiled the details of its latest effort as part of its $165 million AI for Good program. The company plans to spend $40 million over the next five years to support research and public health efforts under its new AI for Health initiative. Microsoft shared its plans on Wednesday, which include giving nonprofits and academic researchers access to the company’s AI tools, cloud computing resources, and collaboration with the company’s data scientists. Certain projects will al...
Novartis Pharma AG | September 19, 2022
Sandoz, a global leader in off-patent medicines, announces further progress on its biosimilar pipeline, with the release of positive results from the integrated ROSALIA Phase I/III clinical trial study for its proposed biosimilar denosumab.
“Biosimilars have the opportunity to create a substantial positive impact on patient access and healthcare systems sustainability. Therefore, this important milestone means that we are one step closer to giving individ...
Future of Healthcare, Medical Devices
Future of Healthcare
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE